Industry/EMA Discuss Early Concerns Over EU’s Safety Signal Reporting Pilot
Executive Summary
Industry representatives have raised some issues around the EU’s pilot program for drug safety signal monitoring and reporting via the revamped EudraVigilance system.
You may also be interested in...
EMA Seeks To Extend EudraVigilance Pilot For Another Year
The pilot was launched to support a phased implementation of new EU requirements relating to monitoring and reporting drug safety information.
UK Regulator Promises Reasonable and Pragmatic Approach For EudraVigilance Inspections
Aware that marketing authorization holders are still finding their way around the EU’s revamped pharmacovigilance database – a UK inspector explains what procedures and processes companies should have in place to show compliance with new requirements to monitor and report safety signals.
Enhanced EudraVigilance System Goes Live, EMA Updates Info For Users
After months of preparations, the European Medicines Agency’s improved pharmacovigilance database has gone live on schedule.